Navigating Biotech Regulation and Innovation

This chapter explores the journeys of immigrant physicians and their impact on the biotech industry, emphasizing the challenges posed by regulatory bodies like the FDA. The speakers discuss the complexities of drug development, the rising costs associated with regulatory scrutiny, and the implications of recent FDA decisions on patient access to innovative therapies.